-Live Mint CCEA clears recommendations on sugar sector made by Rangarajan panel; subsidy burden to rise Pushing ahead with long-pending reforms of the sugar industry, the cabinet on Thursday approved the dismantling of rules requiring sugar mills to sell the sweetener at below-market prices through the public distribution system (PDS) and abolished curbs on open market sale. The cabinet committee on economic affairs cleared the recommendations made by a panel headed by C....
More »SEARCH RESULT
Total Matching Records found : 1649
Novartis patent ruling a victory in battle for affordable medicines-Sarah Boseley
-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...
More »Indian Express-ICIJ probe: Vijay Mallya, Ravikant Ruia in tax havens -Ritu Sarin
-The Indian Express The 612 Indians on the list of those who have invested in tax havens such as the British Virgin Islands include two MPs, a former royal and top industrialists. RITU SARIN puts together details of 20 among them SONU LALCHAND MIRCHANDANI Mirchandani is the founder of popular consumer electronics firm Onida. Mirchandani and his wife, Soni, opened a BVI company called Strong Wing Overseas Ltd in 2006 with an authorised...
More »Common timetable for admissions under RTE-Asha Sridhar
-The Hindu Chennai: Private non-minority unaided schools in the city will, hereafter, have to follow a streamlined admission procedure for intake of students under the 25 per cent quota mandated by the Right of Children to Free and Compulsory Education Act, 2009. A government order (G.O.) issued by the school education department on Monday prescribes not just a common schedule for issue of application forms and declaration of admission results, but also...
More »Supreme Court rules for cheap cancer drug -Subodh Varma
-The Times of India The Supreme Court on Monday rejected pharma giant Novartis AG's plea to preserve its patent over a life-saving cancer drug, Glivec, drawing a huge sigh of relief from thousands of patients in India and in dozens of developing countries as the fear of an almost 15-fold escalation of drug costs receded. It is the biggest setback for multinational pharma companies, which have been denied patent protection...
More »
